Cargando…

Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives

As a critical component of the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) play important roles in cancer initiation and progression. Well‐known signaling pathways, including the transforming growth factor‐β (TGF‐β), Hedgehog (Hh), Notch, Wnt, Hippo, nuclear factor kappa‐B (NF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Zengli, Meng, Qingcai, Xu, Jin, Wang, Wei, Zhang, Bo, Liu, Jiang, Liang, Chen, Hua, Jie, Zhao, Yingjun, Yu, Xianjun, Shi, Si
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859735/ https://www.ncbi.nlm.nih.gov/pubmed/36424360 http://dx.doi.org/10.1002/cac2.12392

Ejemplares similares

The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
por: Fang, Zengli, et al.
Publicado: (2020)

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
por: Mao, Xiaoqi, et al.
Publicado: (2021)

Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT
por: Meng, Qingcai, et al.
Publicado: (2023)

Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis
por: Fang, Zengli, et al.
Publicado: (2020)

Cuproptosis-Related Gene DLAT as a Novel Biomarker Correlated with Prognosis, Chemoresistance, and Immune Infiltration in Pancreatic Adenocarcinoma: A Preliminary Study Based on Bioinformatics Analysis
por: Fang, Zengli, et al.
Publicado: (2023)

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
por: Hua, Jie, et al.
Publicado: (2018)

Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer
por: Lu, Siyuan, et al.
Publicado: (2022)

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis
por: Zhang, Yiyin, et al.
Publicado: (2019)

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
por: Xu, Weiqi, et al.
Publicado: (2019)

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
por: Tang, Rong, et al.
Publicado: (2020)

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
por: Liu, Xiaomeng, et al.
Publicado: (2019)

The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer
por: Tang, Rong, et al.
Publicado: (2020)

Extracellular Polymeric Substances and Biocorrosion/Biofouling: Recent Advances and Future Perspectives
por: Wang, Yanan, et al.
Publicado: (2022)

Recent Advances and Future Perspective in Microbiota and Probiotics
por: Kitazawa, Haruki, et al.
Publicado: (2015)

Polar Microbiology: Recent Advances and Future Perspectives
por: Rampelotto, Pabulo Henrique
Publicado: (2014)

Volcanic electrification: recent advances and future perspectives
por: Cimarelli, Corrado, et al.
Publicado: (2022)

Plant carotenoids: recent advances and future perspectives
por: Sun, Tianhu, et al.
Publicado: (2022)

Recent Advances in the Diagnosis of Classical Swine Fever and Future Perspectives
por: Wang, Lihua, et al.
Publicado: (2020)

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
por: Zhang, Yiyin, et al.
Publicado: (2019)

The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2020)

Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance
por: Zhang, Yiyin, et al.
Publicado: (2019)

A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance
por: Meng, Qingcai, et al.
Publicado: (2020)

Emerging roles of the solute carrier family in pancreatic cancer
por: Wu, Zijian, et al.
Publicado: (2021)

From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors
por: Wei, Miaoyan, et al.
Publicado: (2021)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)

Recent Advances and Future Perspectives on Microfluidic Liquid Handling
por: Nguyen, Nam-Trung, et al.
Publicado: (2017)

Combatting mucosal melanoma: recent advances and future perspectives
por: Tyrrell, Helen, et al.
Publicado: (2018)

The microbiome in pancreatic diseases: Recent advances and future perspectives
por: Ammer-Herrmenau, Christoph, et al.
Publicado: (2020)

Recent Advances and Future Perspectives in Polymer-Based Nanovaccines
por: Pippa, Natassa, et al.
Publicado: (2021)

Recent Advancements and Future Perspectives of Microalgae-Derived Pharmaceuticals
por: Xia, Donghua, et al.
Publicado: (2021)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Biomedical Applications of Electrets: Recent Advance and Future Perspectives
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Recent advances and future perspectives in the therapeutics of prostate cancer
por: Varaprasad, Ganji Lakshmi, et al.
Publicado: (2023)

The rise of genomics in snake venom research: recent advances and future perspectives
por: Rao, Wei-qiao, et al.
Publicado: (2022)

GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation
por: Meng, Qingcai, et al.
Publicado: (2018)

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
por: Zhu, Heng, et al.
Publicado: (2020)

Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment
por: Rong, Zeyin, et al.
Publicado: (2021)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ejjj3inlsf7gmen4i49oct41s